Capsules containing tetrahydrouridine (THU) 250 MG from the cleveland clinic, taussig cancer institute.

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700588P
Awardee
Awarding agency
Obligated
$60,000

Award facts

Opportunity
Contract value 100% obligated
$60,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Cleveland, OH 44195, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to The Cleveland Clinic Foundation for capsules containing tetrahydrouridine (THU) 250 mg, valued at $60,000.00, with an award date of September 6, 2017 and completion date of September 15, 2017. Place of performance is Cleveland, Ohio. The order carries firm fixed price terms and no small business set-aside.

Quick answers

Who was awarded contract HHSN261201700588P?

HHSN261201700588P was awarded to The Cleveland Clinic Foundation by National Cancer Institute (National Institutes of Health) on September 6, 2017.

How much is contract HHSN261201700588P worth?

The government has obligated $60,000 on HHSN261201700588P.

Was contract HHSN261201700588P competed?

The extent of competition for HHSN261201700588P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login